
Stemcell Holdings Inc. Stock Analysis STMM
Stemcell Holdings, Inc. is a holding company, which through its subsidiary, Stemcell Co., Ltd., is engaged in the regenerative medicine-related business. The firm provides two options for stem cell regenerative therapy: autologous adipose derived mesenchymal stem cells (ADMSC) and natural killer cells (NK). The firm provides coordination services to facilitate its stem cell culturing business. Its coordination services include the introduction of patients to clinics, arranging patients’ schedules, and translating between patients and clinics. The firm offers Internet marketing services by providing search engine optimization for clinics. The company also offers property and equipment rental services. The firm operates through its wholly owned subsidiary, Stemcell Co., Ltd.
Read More Stemcell Holdings Inc (STMM) Chart
Key Statistics of Stemcell Holdings Inc (STMM)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.06Volume
-P/E Ratio (TTM)
0.6852 Week Range
Market Cap
1.64MAvg. Volume
-Dividend Yield
-Financial Metrics & Statements of Stemcell Holdings Inc (STMM)
FAQ's for Stemcell Holdings Inc (STMM)
- According to Musaffa’s Shariah screening methodology, Stemcell Holdings Inc (STMM) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.